Home › RegulatoryDesign Therapeutics, Inc. - 10-Q FilingDesign Therapeutics reports quarterly results for period ended September 30, 2026SEC EDGAR · November 4, 2026, 21:11 UTCTickers: $DSGN Read the full article at SEC EDGAR